arrow
M

Marco Carone

university of washington
H指数:31
被引数:3,740

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Household Transmission of SARS-CoV-2 in Washington and Oregon, United States, 2022-2024

2022-2024年美国华盛顿州和俄勒冈州的家庭内SARS-CoV-2传播

2026-07-200
PRE
Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

儿童中与SARS-CoV-2感染风险相关的免疫相关性:一项前瞻性、社区为基础的队列研究

2026-07-180
OAAI
INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024

美国流感家庭传播及基因组多样性:一项前瞻性队列研究,2022-2024

2026-04-200
OAAI
Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination

妊娠期/产后个体与老年人接种RSV疫苗后RSV特异性抗体的持久性比较

2026-03-010
OA
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

SARS-CoV-2变异株抗体反应的免疫相关性分析:ENSEMBLE疫苗有效性试验

2025-09-290
OAAI
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study

呼吸道合胞病毒疾病风险的关联因素:一项前瞻性队列研究

2025-09-260
OAAI
Parental intent to vaccinate children with the updated 2023–2024 COVID-19 vaccine

家长为孩子接种更新版2023–2024年COVID-19疫苗的意愿

Vaccine
IF3.5
2025-08-230
PRE
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023
2025-03-010
PRE
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States

mRNA新型冠状病毒肺炎疫苗和杂交免疫预防美国成人SARS-CoV-2感染和症状新型冠状病毒肺炎的有效性

2025-01-080
PRE
Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019-2021
2024-11-010
PRE
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

COVE试验中第三剂mRNA-1273的Omicron新型冠状病毒肺炎免疫相关分析

2024-09-110
OAAI
Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting

在社区环境中SARS-CoV-2快速抗原和分子检测的比较诊断效用

2024-03-262
PRE
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
2023-09-297
OAAI